Trade Summary

5 days ago, Paolini John F., serving as CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, Plc (KNSA), sold 58,424 shares at $53.71 per share, for a total transaction value of $3,137,823.00. Following this transaction, Paolini John F. now holds 65,623 shares of KNSA.

This sale represents a 47.00% decrease in Paolini John F.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026, 4 days after the trade was made.

Kiniksa Pharmaceuticals International, Plc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.